Skip to main content
. Author manuscript; available in PMC: 2011 Apr 13.
Published in final edited form as: Microcirculation. 2008 Jul;15(5):461–471. doi: 10.1080/10739680701833804

Figure 2.

Figure 2

Western immunoblots of rabbit (A) and human (B) erythrocyte membranes and platelet membranes (positive controls) probed with an antibody directed against the IP receptor. A: Lanes 1–3 = individual rabbit erythrocyte membrane preparations (representative of 7 studies) and lane 4 = rabbit platelet membranes. B: Lanes 1–3 = individual human erythrocyte membranes (representative of 14 studies) and lane 4 = human platelet membranes.

HHS Vulnerability Disclosure